comparemela.com

Latest Breaking News On - Kalvista pharmaceuticals daily - Page 5 : comparemela.com

KalVista Pharmaceuticals, Inc (NASDAQ:KALV) Major Shareholder Venrock Healthcare Capital Par Acquires 17,605 Shares

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par acquired 17,605 shares of the stock in a transaction dated Wednesday, January 3rd. The stock was acquired at an average cost of $12.20 per share, with a total value of $214,781.00. Following the completion of the transaction, the insider now owns […]

KalVista Pharmaceuticals (NASDAQ:KALV) Issues Earnings Results

KalVista Pharmaceuticals (NASDAQ:KALV – Get Free Report) issued its quarterly earnings results on Thursday. The specialty pharmaceutical company reported ($0.80) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.76) by ($0.04), MarketWatch Earnings reports. KalVista Pharmaceuticals Stock Performance Shares of NASDAQ KALV opened at $8.16 on Friday. The company has a 50 […]

KalVista Pharmaceuticals (NASDAQ:KALV) Stock Price Crosses Below 50 Day Moving Average of $10 21

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) shares passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $10.21 and traded as low as $8.96. KalVista Pharmaceuticals shares last traded at $9.25, with a volume of 120,390 shares traded. Analysts Set New Price […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.